Literature DB >> 24968197

Telestroke in an urban setting.

Shawna Cutting1, James J Conners, Vivien H Lee, Sarah Song, Shyam Prabhakaran.   

Abstract

BACKGROUND: Telestroke is a viable alternative in rural areas where neurologists or stroke expertise is unavailable. Urban applications of telestroke have not been previously described.
MATERIALS AND METHODS: All patients evaluated using remote telestroke technology at four urban spoke hospitals between March 2011 and March 2013 were included in this analysis. Telestroke services were provided by vascular fellowship-trained neurologists at one academic stroke center. Patient characteristics, time to initiation of consult, and treatment decisions were prospectively recorded. Stroke triage protocols and thrombolysis rates prior to initiation of telestroke were also obtained.
RESULTS: Four hundred ninety-eight patients were evaluated during the study period; mean age was 64.5 years, and 60.4% were female. Median time from initial emergency room call to start of teleconsult was 5 (range, 1-51) minutes. Average length of teleconsult was 30 minutes. Technical difficulties occurred in 80 (16.0%) teleconsults, but only 1 was major. Daytime calls (8 a.m.-5 p.m. Monday-Friday) accounted for 38.2% of teleconsults. Two hundred eighty-one patients (56.4%) were determined by teleconsult to have an acute ischemic stroke or transient ischemic attack (TIA). In 72 patients (14.5% overall; 25.6% of all ischemic stroke/TIA patients), intravenous alteplase (tissue plasminogen activator) was recommended. Transfer to the hub hospital occurred in 75 patients (15.1%).
CONCLUSIONS: Telestroke is a rapid and effective way to assess patients with suspected acute stroke in an urban setting. Its use may increase access to stroke neurologists and improve thrombolysis rates where competing responsibilities may delay, prevent, and even dissuade on-site evaluation by neurologists.

Entities:  

Keywords:  emergency medicine/teletrauma; telecommunications; telemedicine; teleneurology

Mesh:

Substances:

Year:  2014        PMID: 24968197      PMCID: PMC4148054          DOI: 10.1089/tmj.2013.0348

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  10 in total

1.  The use of telemedicine in combination with a new stroke-code-box significantly increases t-PA use in rural communities.

Authors:  Guntram W Ickenstein; M Horn; J Schenkel; B Vatankhah; U Bogdahn; R Haberl; H J Audebert
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts Primary Stroke Service Program.

Authors:  Natalia S Rost; Eric E Smith; Muhammad A Pervez; Philip Mello; Paul Dreyer; Lee H Schwamm
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-04-24

3.  Telestroke-guided intravenous tissue-type plasminogen activator treatment achieves a similar clinical outcome as thrombolysis at a comprehensive stroke center.

Authors:  Syed F Zaidi; Mouhammad A Jumma; Xabier N Urra; Maxim Hammer; Lori Massaro; Vivek Reddy; Tudor Jovin; Ridwan Lin; Lawrence R Wechsler
Journal:  Stroke       Date:  2011-09-01       Impact factor: 7.914

4.  Racial disparities in tissue plasminogen activator treatment rate for stroke: a population-based study.

Authors:  Amie W Hsia; Dorothy F Edwards; Lewis B Morgenstern; Jeffrey J Wing; Nina C Brown; Regina Coles; Sarah Loftin; Andrea Wein; Sara S Koslosky; Sabiha Fatima; Brisa N Sánchez; Ali Fokar; M Chris Gibbons; Nawar Shara; Annapurni Jayam-Trouth; Chelsea S Kidwell
Journal:  Stroke       Date:  2011-06-30       Impact factor: 7.914

Review 5.  Reasons why few patients with acute stroke receive tissue plasminogen activator.

Authors:  Kara Z Bambauer; S Claiborne Johnston; Derek E Bambauer; Justin A Zivin
Journal:  Arch Neurol       Date:  2006-05

Review 6.  Developing and implementing future stroke therapies: the potential of telemedicine.

Authors:  Marc Fisher
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

7.  Use of telemedicine and other strategies to increase the number of patients that may be treated with intravenous thrombolysis.

Authors:  Gisele Sampaio Silva; Lee H Schwamm
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

8.  Cost-effectiveness of hub-and-spoke telestroke networks for the management of acute ischemic stroke from the hospitals' perspectives.

Authors:  Jeffrey A Switzer; Bart M Demaerschalk; Jipan Xie; Liangyi Fan; Kathleen F Villa; Eric Q Wu
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-12-04

9.  Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.

Authors:  Gregory J Del Zoppo; Jeffrey L Saver; Edward C Jauch; Harold P Adams
Journal:  Stroke       Date:  2009-05-28       Impact factor: 7.914

10.  Access to Expert Stroke Care with Telemedicine: REACH MUSC.

Authors:  Abby Swanson Kazley; Rebecca C Wilkerson; Edward Jauch; Robert J Adams
Journal:  Front Neurol       Date:  2012-03-21       Impact factor: 4.003

  10 in total
  2 in total

1.  HRSA's evidence-based tele-emergency network grant program: Multi-site prospective cohort analysis across six rural emergency department telemedicine networks.

Authors:  Sarah Heppner; Nicholas M Mohr; Knute D Carter; Fred Ullrich; Kimberly A S Merchant; Marcia M Ward
Journal:  PLoS One       Date:  2021-01-12       Impact factor: 3.240

2.  Building cohesion in distributed telemedicine teams: findings from the Department of Veterans Affairs National Telestroke Program.

Authors:  Himalaya Patel; Teresa M Damush; Edward J Miech; Nicholas A Rattray; Holly A Martin; April Savoy; Laurie Plue; Jane Anderson; Sharyl Martini; Glenn D Graham; Linda S Williams
Journal:  BMC Health Serv Res       Date:  2021-02-06       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.